FRI-271 - Comparison of efficacy and safety of ombitasvir/paritaprevir/ ritonavir and dasabuvir ± ribavirin between Asian and western HCV GT1b-infected patients

Autor: Wei, L., Luo, Y., Chuang, W.-L., Paik, S.W., Yu, M.-L., Fredrick, L.M., Campbell, A., Trinh, R., Enejosa, J., Shulman, N.S., Heo, J., Mobashery, N.
Zdroj: In Journal of Hepatology 2017 66(1) Supplement:S531-S532
Databáze: ScienceDirect
Externí odkaz: